Bristol-Myers Squibb
BMY
#169
Rank
NZ$219.71 B
Marketcap
NZ$107.49
Share price
0.79%
Change (1 day)
30.50%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$7.93

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$8.26. In 2025 the company made an earnings per share (EPS) of NZ$6.32 an increase over its 2024 EPS that were of NZ-$8.08.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.9325.32%
2025NZ$6.32-178.28%
2024NZ-$8.08-213.92%
2023NZ$7.0930.2%
2022NZ$5.45-6.04%
2021NZ$5.80-179.29%
2020NZ-$7.31-281.37%
2019NZ$4.03-27.21%
2018NZ$5.54
2016NZ$4.88175.26%
2015NZ$1.77-19.83%
2014NZ$2.21-22.44%
2013NZ$2.8534.48%
2012NZ$2.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 47.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60 16.15%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.30-84.29%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$10.70 29.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$56.47 583.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.77 284.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.62-56.18%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$4.31-47.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$1.82-78.03%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$13.02 57.52%๐Ÿ‡ฌ๐Ÿ‡ง UK